Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a Phase III Trial.
Mei W-J, Wang X-Z, Li Y-F, Sun Y-M, Yang C-K, Lin J-Z et al.
Ann Surg 2023; 277: 557-564.
In this study that included 589 procedures, neoadjuvant chemotherapy with radiotherapy had similar effect on complete pathological response and downstaging. Radiotherapy increase the risk of needing an ileostomy: 63.6 versus 52.2 per cent, P= 0.008.
Comment: The late outcomes of this trial will reveal whether additional radiotherapy is worthwhile.
30 May 2023Read paper
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.